Using genetic testing, a potential new face has been put on one of medicine's oldest, most commonly used and dreaded medications. Warfarin is an anticoagulant medication prescribed worldwide to ...

Warfarin is a medication that, with few exceptions, is dosed to effect. When the INR does not respond as predicted, it is important to consider possible causes before the warfarin dose is adjusted.

Using genetic testing to help personalize doses of warfarin therapy given to patients undergoing elective orthopedic surgery appears to lower the risk of combined adverse events compared with ...

Boston, MA - Results of a randomized trial show that high-intensity warfarin, with a target INR of more than 3.0, was not superior to a more moderate target of 2.0 to 3.0 in preventing recurrent ...

You should not take warfarin if you have a bleeding disorder, a blood cell disorder, blood in your urine or stools, stomach bleeding, very high blood pressure, an infection of the lining of your heart ...

The US Food and Drug Administration (FDA) has concluded that inaccurate results from the point-of-care device used to measure international normalized ratio (INR) values in warfarin-treated patients ...

Please provide your email address to receive an email when new articles are posted on . Venous thromboembolism causes substantial morbidity and mortality in patients with cancer. Patients with cancer ...

Athens, Greece - 15 April 2016: Patients have poor knowledge of warfarin which may increase their risk of serious side effects, according to research presented today at EuroHeartCare 2016 by Dr ...

Please provide your email address to receive an email when new articles are posted on . Patients taking warfarin who developed an upper respiratory tract infection were at increased risk for excessive ...